Search - tctmd.com

Displaying 281 - 300 of 303

Sort: Relevancy | Date

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

Yael L. Maxwell

April 26, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Caitlin E. Cox

September 20, 2012

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

News Daily News

La Estrategia Invasiva Precoz en Pacientes STEMI Mejora la Supervivencia

September 18, 2012

News Daily News

Early Invasive Strategy in NSTEMI Patients Improves Survival

September 18, 2012

Presentation

Use of Invasive Strategy in NSTEMI Is a Major Determinant of Improved Long-term Survival

Presenter: E. Puymirat

September 17, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

Long-term Outcomes Similar for PCI, CABG in Octogenarians

July 16, 2012

News Daily News

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

July 03, 2012

News Daily News

Meta Análisis: La Estrategia Invasiva Precoz es la Mejor en Pacientes Diabéticos con SCASEST

July 03, 2012

Presentation

Invasive vs. Conservative Strategy in Patients with Diabetes and Non-ST-Segment Elevation ACS

Presenter: Michelle L. O?Donoghue

July 02, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

Caitlin E. Cox

April 26, 2012

News Daily News

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

March 06, 2012

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

Advertisement

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

La Estrategia Invasiva Precoz en Pacientes STEMI Mejora la Supervivencia

Early Invasive Strategy in NSTEMI Patients Improves Survival

Use of Invasive Strategy in NSTEMI Is a Major Determinant of Improved Long-term Survival

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Long-term Outcomes Similar for PCI, CABG in Octogenarians

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

Meta Análisis: La Estrategia Invasiva Precoz es la Mejor en Pacientes Diabéticos con SCASEST

Invasive vs. Conservative Strategy in Patients with Diabetes and Non-ST-Segment Elevation ACS

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content